Patient characteristics of the sample (n = 231) used to assess reliability and validity of the CDQ-24 (Stage III)
| Patient characteristics | Cervical dystonia | Blepharospasm |
|---|---|---|
| *p = 0.001, cervical dystonia v blepharospasm. | ||
| †No previous botulinum toxin treatment. | ||
| SD, standard deviation. | ||
| Number | 139 | 92 |
| Sex (% women) | 64.7 | 60.9 |
| Mean (SD) age (years)* | 53 (12) | 64 (10) |
| Mean (SD) disease duration (years) | 8.0 (5.9) | 6.9 (6.8) |
| Severity of dystonia | Tsui score (mean±SD) | Global impression score:0–4 (mean±SD) |
| 6.7 (3.7) | 2.3 (0.9) | |
| Neck pain (%) | 67.1 | – |
| Additional dystonic features (%) | Segmental dystonia: 5.8 | Meige’s syndrome: 28.3 |
| De novo patients (%)† | 22.3 | 21.7 |
| Married (%) | 74.8 | 74.4 |
| Employment rate (% of patients⩽60 years only) | 50.0 (n = 98) | 57.1(n = 35) |